DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Aluminium clofibrate
Aluminium clofibrate
(12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Clofibrate Causes an Upregulation of PPAR- Target Genes but Does Not
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark
Lääkeaineiden Yleisnimet (INN-Nimet) 21.6.2021
Alphabetical Listing of ATC Drugs & Codes
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
2 12/ 35 74Al
(12) United States Patent (10) Patent No.: US 8,821,928 B2 Hemmingsen Et Al
Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide
(12) United States Patent (10) Patent No.: US 8,637,524 B2 Rao Et Al
Pharmaceuticals Appendix
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2016) Annotated for Statistical Reporting Purposes
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
Accessibility Improving Information Using Online Patient Drug Reviews
United States Patent (19) 11 Patent Number: 5,811,547 Nakamichi Et Al
Improving Information Accessibility Using Online Patient Drug Reviews
Top View
Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark∗
Increased Risk of Hyperlipidemia in Patients with Anxiety Disorders: a Population-Based Study
(12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
Regulatory Change in Pharmaceutical Price: Evidence from A
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
NIH Public Access Author Manuscript Mutat Res
Pharmaceutical Appendix to the Tariff Schedule 2
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
'Essays in Regulation of Pharmaceutical Markets'
(INN-Nimet) 8.12.2020
Ivermectin Interest Group Submission
The Effect of Short-Term Pretreatment with Peroxisome Proliferators on The
Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark
Pharmaceuticals Appendix
1246 Cardiovascular Drugs
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving